Mcdaniel Terry & Co. Buys 459 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mcdaniel Terry & Co. grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 70,165 shares of the medical equipment provider’s stock after purchasing an additional 459 shares during the quarter. Intuitive Surgical makes up approximately 2.9% of Mcdaniel Terry & Co.’s investment portfolio, making the stock its 13th largest holding. Mcdaniel Terry & Co.’s holdings in Intuitive Surgical were worth $34,470,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical in the second quarter worth about $26,000. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the period. Creekmur Asset Management LLC grew its position in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares during the period. LGT Financial Advisors LLC grew its position in shares of Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares during the period. Finally, Delos Wealth Advisors LLC grew its position in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $511.63 on Friday. The stock has a market capitalization of $181.48 billion, a P/E ratio of 92.35, a PEG ratio of 5.40 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $523.34. The firm’s 50-day moving average is $486.71 and its two-hundred day moving average is $440.96.

Insiders Place Their Bets

In related news, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the sale, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at $3,638,990. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the transaction, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at $3,638,990. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Amal M. Johnson sold 2,943 shares of the company’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the transaction, the director now owns 12,275 shares in the company, valued at $5,441,507.50. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 52,192 shares of company stock worth $25,398,571 in the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of analyst reports. Leerink Partners lifted their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Barclays boosted their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research report on Thursday, July 18th. Royal Bank of Canada raised their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Piper Sandler reaffirmed an “overweight” rating and issued a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Truist Financial lifted their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research report on Monday, October 14th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.